FATE
Fate Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$2.48
+2.48%Leverage
- Debt / equity
- 0.49x
- Net debt / equity
- 0.28x
- Debt / assets
- 0.29x
- Debt / EBITDA
- -0.65x
- Net debt / EBITDA
- -0.37x
Liquidity & coverage
- Current ratio
- 4.85x
- Quick ratio
- 4.85x
- Cash ratio
- 4.72x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $125.4M
Cash & dividend
- FCF / debt
- -1.40x
- Cash flow / debt
- -1.35x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026